Abstract
A peer-reviewed journal would not survive without the dedication and insightful commentaries of the reviewers, whose efforts often go unrecognized. ASSAY and Drug Development Technologies covers a wide range of subjects, requiring our reviewers to be especially attentive and adept at evaluating new technologies.
The Editorial leadership of ASSAY and Drug Development Technologies is very grateful for the support of the many highly qualified peer reviewers who have dedicated their time to reviewing our manuscripts. We would like to show our appreciation by thanking the following for their assistance with review of manuscripts for the Journal in 2014.
Malgorzata Adamczyk
Michele Agler
Beatrice Alpha-Bazin
Sina Bavari
John Beutler
Robert Bostwick
Shawn Burgess
Matthew Butchbach
Jim Cali
Bastien Cautain
Jeanne Chiaravalli
Andrew Crowe
Tim Dale
Garry Dallmann
Robert Damoiseaux
Tapan Das
Mindy Davis
Christine DiDonato
Yuhong Du
Jeff Essner
David Evans
Darryl Falzarano
Rong Fan
Ye Fang
Steven Farber
Marc Ferrer
Michael Finley
Fraser Glickman
Vassilis Gorgoulis
Michael Gottesman
Christopher Heise
James Herrington
Stephen Hess
Adam Hill
Thomas Hoenen
Tod Holler
Richard Honkanen
Derek Hook
Keith Houck
Konrad Howitz
Jim Inglese
Phil Iversen
Yong Jia
Susan Judge
Greg Kaczorowski
Douglas Krafte
Krause Henry
Asmita Kumar
Martha Larsen
Jin-Ching Lee
Qianjun Li
Thomas Lundbäck
Haiching Ma
Franck Madoux
Michael Mancini
Patricia McDonald
Joe McGivern
Andrew Napper
David Newman
Young-Whan Park
Jeff Reagan
Stephan Schurer
Caroline Shamu
Adam Shapiro
Min Shen
Anton Simeonov
Kaylene Simpson
Peter Simpson
Jennifer Smith
Lorey Smith
Kelly Solly
Noel Southall
Timothy Spicer
Saulius Sumanas
Adam Szafran
Ikumi Tamai
Akiyoshi Taniguchi
Elena Trepakova
Martin van Royen
Nate Vandesteeg
Rafaele Velotta
Grover Waldrop
En-Duo Wang
Jun Wang
Yueming Wang
Venita Watson
David Weaver
Tom Wehrman
Mark Wigglesworth
Heike Wulff
Liju Yang
Guido Zaman
Haoyu Zeng
Paul Zuck